An observational study in Trigger Finger, Trigger Digit and Stenosing Tenosynovitis, sponsored by University of Massachusetts, Lowell. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-20.
Sponsored by University of Massachusetts, Lowell · Observational
Trigger finger is a common disorder of the hand which causes pain at the A1 pulley, inflammation, stiffness and/or snapping during movement. This observational study compared all of the possible treatments and combinations of treatments for trigger finger at the A1 pulley, including surgery, cortisone injections and hand therapy.
Trigger finger is a common disorder of the hand which causes pain at the A1 pulley, inflammation, stiffness or snapping during movement. This can be very debilitating. Current treatment includes local steroid injection, oral NSAIDS, resting orthoses, physical or occupational therapy and surgical intervention. The aim of this prospective study with an observational design was to determine the outcome between surgical, hand therapy rehabilitation, and corticosteroid injection interventions for trigger finger. There were 6 treatment groups: surgery, corticosteroid injection, 1 visit of hand therapy for orthosis fabrication and therapeutic exercise, hand therapy in combination with cortisone injection, Modality hand therapy alone (ongoing visits) or with corticosteroid injections.
93 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.
This study's enrollment of 86 is above the median of 68 across 14 observational studies indexed under Trigger Finger Disorder.
Browse Trigger Finger Disorder studies →University of Massachusetts, Lowell is the lead sponsor of 12 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients undergoing medical treatment or hand therapy for trigger finger in digits #2-5 at the hand clinic. Patients were dropped from the study if they had changed to a different treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who underwent surgical release of A1 pulley
Procedure: surgery
Patients who underwent local corticosteroid injections only, and no other treatment
Procedure: corticosteroid injections
1 visit: orthosis fabrication, range of motion, nodule and ice massage.
Other: Hand Therapy
This group of participants received a combination of corticosteroid injection in the affected finger and one visit of hand therapy.
Procedure: corticosteroid injections · Other: Hand Therapy
Ongoing hand therapy treatment, which included the above plus modalities such as ultrasound or iontophoresis.
Other: Modality Hand Therapy
Ccombination of local cortiscosteroid injection to the affected digit and ongoing hand therapy with modalities.
Procedure: corticosteroid injections · Other: Modality Hand Therapy
A1 pulley release of finger
corticosteroid injection to A1 pulley
orthosis fabrication, therapeutic exercise for range of motion to digits, ice massage, nodule massage, patient education,
Also known as: physical therapy, occupational therapy
orthosis fabrication, therapeutic exercise for range of motion to digits, ice massage, nodule massage, patient education, plus modalities such as ultrasound, iontophoresis
Change in Functional use using Quick DASH 6 weeks
Change from baseline to 6 weeks Quick DASH
Time frame: Day 1, 6 weeks
Change in Functional use using Quick DASH 3 months
Change from baseline to 3 months Quick DASH
Time frame: Day 1, 3 months
Change in Functional use using Quick DASH 6 months
Change from baseline to 6 months Quick DASH
Time frame: Day 1, 6 months
Change in Edema 6 weeks
Baseline to 6 weeks Circumferential measurement in centimeters of the proximal phalanx
Time frame: day 1, 6 weeks
Change in Edema 3 months
Baseline to 3 months weeks Circumferential measurement in centimeters of the proximal phalanx
Time frame: day 1, 3 months
Change in Edema 6 months
Baseline to 6 months weeks Circumferential measurement in centimeters of the proximal phalanx
Time frame: day 1, 6 months
Change in Pain on a likert scale 6 weeks
Baseline to 6 weeks pain on a 0-10 scale
Time frame: 1 day, 6 weeks
Change in Pain on a likert scale 3 months
Baseline to 3 months pain on a 0-10 scale
Time frame: 1 day, 3 months
Change in Pain on a likert scale 6 months
Baseline to 6 months pain on a 0-10 scale
Time frame: 1 day, 6 months
Change in Range of motion 6 weeks
Baseline to 6 weeks flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
Time frame: 1 day, 6 weeks
Change in Range of motion 3 months
Baseline to 3 months flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
Time frame: 1 day, 3 months
Change in Range of motion 6 months
Baseline to 6 months flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
Time frame: 1 day, 6 months
Change in Severity or Grade of triggering 6 weeks
Baseline to 6 weeks Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
Time frame: 1 day, 6 weeks
Change in Severity or Grade of triggering 3 months
Baseline to 3 months Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
Time frame: 1 day, 3 months
Change in Severity or Grade of triggering 6 months
Baseline to 6 months Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
Time frame: 1 day, 6 months
No study locations are listed for this record.
Plan to share: No — There are no plans for sharing the IPD
Ran from Dec 2007 to primary completion in Dec 2012, 59 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Massachusetts, Lowell